OpGen ROE 2014-2024 | OPGN
OpGen ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-09-30 | $-0.01B | $0.00B | 137.50% |
2024-06-30 | $-0.02B | $-0.01B | 287.50% |
2024-03-31 | $-0.03B | $-0.01B | 830.77% |
2023-12-31 | $-0.03B | $-0.01B | -1885.71% |
2023-09-30 | $-0.03B | $0.00B | -400.00% |
2023-06-30 | $-0.04B | $0.01B | -389.47% |
2023-03-31 | $-0.04B | $0.01B | -255.17% |
2022-12-31 | $-0.04B | $0.01B | -183.13% |
2022-09-30 | $-0.04B | $0.01B | -141.38% |
2022-06-30 | $-0.03B | $0.03B | -97.78% |
2022-03-31 | $-0.03B | $0.03B | -91.89% |
2021-12-31 | $-0.04B | $0.04B | -105.00% |
2021-09-30 | $-0.04B | $0.03B | -100.00% |
2021-06-30 | $-0.04B | $0.04B | -119.35% |
2021-03-31 | $-0.04B | $0.05B | -143.69% |
2020-12-31 | $-0.03B | $0.02B | -146.48% |
2020-09-30 | $-0.02B | $0.02B | -162.96% |
2020-06-30 | $-0.02B | $0.02B | -194.29% |
2020-03-31 | $-0.01B | $0.01B | -288.89% |
2019-12-31 | $-0.01B | $0.00B | -650.00% |
2019-09-30 | $-0.01B | $0.00B | -800.00% |
2019-06-30 | $-0.01B | $0.00B | -430.77% |
2019-03-31 | $-0.01B | $0.00B | -329.41% |
2018-12-31 | $-0.01B | $0.00B | -236.36% |
2018-09-30 | $-0.01B | $0.00B | -240.00% |
2018-06-30 | $-0.01B | $0.01B | -240.00% |
2018-03-31 | $-0.01B | $0.01B | -433.33% |
2017-12-31 | $-0.02B | $0.00B | -1500.00% |
2017-09-30 | $-0.02B | $0.00B | -1133.33% |
2017-06-30 | $-0.02B | $0.00B | -1520.00% |
2017-03-31 | $-0.02B | $0.00B | -533.33% |
2016-12-31 | $-0.02B | $0.00B | -470.59% |
2016-09-30 | $-0.02B | $0.00B | -380.95% |
2016-06-30 | $-0.02B | $0.01B | -266.67% |
2016-03-31 | $-0.02B | $0.00B | -258.06% |
2015-12-31 | $-0.02B | $0.01B | -300.00% |
2015-09-30 | $-0.01B | $0.01B | -430.77% |
2015-06-30 | $-0.01B | $0.01B | -4400.00% |
2015-03-31 | $-0.01B | $0.00B | 400.00% |
2014-12-31 | $-0.01B | $0.00B | 600.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.046B | $0.003B |
OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.821B | 26.97 |
CVS Health (CVS) | United States | $84.326B | 10.48 |
Elevance Health (ELV) | United States | $78.255B | 10.10 |
Cencora (COR) | United States | $58.178B | 20.24 |
DiDi Global (DIDIY) | China | $23.485B | 24.95 |
Natera (NTRA) | United States | $22.086B | 0.00 |
Labcorp Holdings (LH) | United States | $21.684B | 17.59 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.804B | 0.00 |
Solventum (SOLV) | United States | $12.836B | 13.59 |
CochLear (CHEOY) | Australia | $12.824B | 0.00 |
ICON (ICLR) | Ireland | $12.156B | 11.30 |
Revvity (RVTY) | United States | $11.802B | 20.31 |
Viatris (VTRS) | United States | $10.833B | 3.72 |
Avantor (AVTR) | United States | $9.247B | 13.44 |
Medpace Holdings (MEDP) | United States | $9.225B | 24.50 |
HealthEquity (HQY) | United States | $8.646B | 37.87 |
Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.808B | 15.30 |
Caris Life Sciences,�Inc (CAI) | United States | $6.930B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.971B | 29.27 |
BrightSpring Health Services (BTSG) | United States | $3.760B | 34.50 |
Sotera Health (SHC) | United States | $3.296B | 18.73 |
Surgery Partners (SGRY) | United States | $2.870B | 37.32 |
Alignment Healthcare (ALHC) | United States | $2.750B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.622B | 100.97 |
Concentras Parent (CON) | United States | $2.619B | 15.13 |
Organon (OGN) | United States | $2.576B | 2.74 |
Progyny (PGNY) | United States | $2.038B | 44.87 |
Ardent Health (ARDT) | United States | $1.981B | 8.45 |
PACS (PACS) | United States | $1.957B | 0.00 |
Premier (PINC) | United States | $1.778B | 13.49 |
GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
Teladoc Health (TDOC) | United States | $1.553B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.303B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
CareDx (CDNA) | United States | $1.129B | 17.64 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.948B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.846B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
Nutex Health (NUTX) | United States | $0.643B | 9.73 |
Embecta (EMBC) | United States | $0.619B | 4.17 |
InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
SBC Medicals (SBC) | United States | $0.546B | 0.00 |
LifeMD (LFMD) | United States | $0.535B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
So-Young (SY) | China | $0.440B | 0.00 |
Omada Health (OMDA) | $0.434B | 0.00 | |
Enhabit (EHAB) | United States | $0.368B | 30.29 |
Performant Healthcare (PHLT) | United States | $0.335B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.330B | 0.00 |
Beauty Health (SKIN) | United States | $0.263B | 0.00 |
Oncology Institute (TOI) | United States | $0.216B | 0.00 |
DocGo (DCGO) | United States | $0.159B | 26.00 |
Pheton Holdings (PTHL) | China | $0.132B | 0.00 |
Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
KindlyMD (NAKA) | United States | $0.074B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.067B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
ModivCare (MODV) | United States | $0.060B | 0.00 |
Biodesix (BDSX) | United States | $0.046B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
OSR Holdings (OSRH) | United States | $0.024B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |